LIVN News and Press, LivaNova PLC From 11/02/19

LivaNova PLC (LIVN) Q3 2019 Earnings Conference Call October 30, 2019, 08:00 ET Company Participants Matthew Dodds - SVP, Corporate Development Damien McDonald - CEO & Director Thad Huston - CFO Conference Call Participants Rajbir Denhoy - Jefferies Rick Wise - Stifel...

Company working to raise more awareness of epilepsy through partnerships LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, honors National Epilepsy Awareness Month in the United States this November. The company is working to bring more awareness t...

Image source: The Motley Fool. LivaNova PLC   (NASDAQ: LIVN) Q3 2019 Earnings Call Oct 30, 2019 , 8:00 a.m. ET Operator Continue reading

The following slide deck was published by LivaNova PLC in conjunction with their 2019 Q3 earnings Read more ...

LivaNova PLC (NASDAQ: LIVN ): Q3 Non-GAAP EPS of $0.84 beats by $0.09 ; GAAP EPS of $0.66 beats by $0.18 . More news on: LivaNova PLC, Earnings news and commentary, Healthcare stocks news, Read more ...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended September 30, 2019. For the third quarter of 2019, worldwide sales from continuing operations were $268.6 million, a decrease of 1.3 percent on a reported b...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced Damien McDonald, Chief Executive Officer, will present at the Stifel 2019 Healthcare Conference on Wednesday, November 20 in New York at 3 p.m. Eastern Time. The discussion will be avai...

Study is latest in a series to suggest similar findings LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced the publication of a new study in Neurology , which suggests that chronic epilepsy may be associated with key measures o...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its third quarter 2019 results on Wednesday, October 30, 2019 at 12 p.m. London time (8 a.m. Eastern Daylight Time). The Company will release its third quarter 2019 r...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced the first patient enrolled in “A P r ospective, Multi-c e nter, Randomized C ontrolled Blinded Trial Dem o nstrating the Safety and Effectiveness of V NS Therapy ® System as ...